http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AU-2008335855-B2
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_966a6c1f382ec9bcb5e3839dfd73e5b8 |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-96411 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57419 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57473 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57423 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57407 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-574 |
| filingDate | 2008-12-08^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2012-08-30^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8e90c8de9081b0df23ba889110e41a6a http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b7a823d90892128c3254eb73490dd4e1 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9c99c9d43520edea72dd7178e84c6527 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_348c0d72a2e01c15ca60ea8380cc0d91 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_59c4b8bc33a1a073a13ba86a356a022e |
| publicationDate | 2012-08-30^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | AU-2008335855-B2 |
| titleOfInvention | Seprase as a marker for cancer |
| abstract | The present invention relates to a method aiding in the assessment of cancer. It discloses the use of the human fibroblast activation protein (FAP/seprase) as a universal marker of different cancer types. Seprase aids in the assessment of pulmonary or lung cancer (LC) or of colon cancer, e.g. of non-small cell lung carcinoma (NSCLC) or colorectal cancer (CRC), but also likely of other specific types of cancer. Such specific cancer types are e.g. esophagus, head and neck cancer, stomach cancer, bile duct cancer, pancreas cancer, kidney cancer, cervix cancer, ovary cancer, breast cancer, bladder cancer, endometrium cancer or prostate cancer. Furthermore, it especially relates to a method for assessing cancer from a liquid sample, derived from an individual by measuring seprase in said sample. Measurement of seprase can, e.g., be used in the early detection of cancer or in the surveillance of patients who undergo surgery. |
| priorityDate | 2007-12-10^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Showing number of triples: 1 to 236 of 236.